DNA and Gene Chip Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4101659
- 120 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global DNA and Gene Chip market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global DNA and Gene Chip market segmented into
Gene expression
Complementary DNA microarrays (cDNA)
Based on the end-use, the global DNA and Gene Chip market classified into
Gene expression
Cancer diagnostics & treatments
Drug discovery
Genetics
SNP analysis
Others
Based on geography, the global DNA and Gene Chip market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
AFFYMETRIX INC
AGILENT TECHNOLOGIES INC
BIOMIEUX SA
BIOMETRIX TECHNOLOGY INC
BIONEER CORP
CAPITALBIO CORP
EUROFINS MWG OPERON
GREINER BIO-ONE
ILLUMINA INC
LC SCIENCES
LIFEGEN TECHNOLOGIES
LIFE TECHNOLOGIES CORP
MACROGEN INC
MICROARRAYS INC
NGK INSULATORS LTD
ROCHE NIMBLEGEN INC
SIGMA-ALDRICH
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL DNA AND GENE CHIP INDUSTRY
2.1 Summary about DNA and Gene Chip Industry
2.2 DNA and Gene Chip Market Trends
2.2.1 DNA and Gene Chip Production & Consumption Trends
2.2.2 DNA and Gene Chip Demand Structure Trends
2.3 DNA and Gene Chip Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Oligonucleotide DNA microarrays (oDNA)
4.2.2 Complementary DNA microarrays (cDNA)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Gene expression
4.3.2 Cancer diagnostics & treatments
4.3.3 Drug discovery
4.3.4 Genetics
4.3.5 SNP analysis
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Oligonucleotide DNA microarrays (oDNA)
5.2.2 Complementary DNA microarrays (cDNA)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Gene expression
5.3.2 Cancer diagnostics & treatments
5.3.3 Drug discovery
5.3.4 Genetics
5.3.5 SNP analysis
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Oligonucleotide DNA microarrays (oDNA)
6.2.2 Complementary DNA microarrays (cDNA)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Gene expression
6.3.2 Cancer diagnostics & treatments
6.3.3 Drug discovery
6.3.4 Genetics
6.3.5 SNP analysis
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Oligonucleotide DNA microarrays (oDNA)
7.2.2 Complementary DNA microarrays (cDNA)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Gene expression
7.3.2 Cancer diagnostics & treatments
7.3.3 Drug discovery
7.3.4 Genetics
7.3.5 SNP analysis
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Oligonucleotide DNA microarrays (oDNA)
8.2.2 Complementary DNA microarrays (cDNA)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Gene expression
8.3.2 Cancer diagnostics & treatments
8.3.3 Drug discovery
8.3.4 Genetics
8.3.5 SNP analysis
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Oligonucleotide DNA microarrays (oDNA)
9.2.2 Complementary DNA microarrays (cDNA)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Gene expression
9.3.2 Cancer diagnostics & treatments
9.3.3 Drug discovery
9.3.4 Genetics
9.3.5 SNP analysis
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AFFYMETRIX INC
10.1.2 AGILENT TECHNOLOGIES INC
10.1.3 BIOMIEUX SA
10.1.4 BIOMETRIX TECHNOLOGY INC
10.1.5 BIONEER CORP
10.1.6 CAPITALBIO CORP
10.1.7 EUROFINS MWG OPERON
10.1.8 GREINER BIO-ONE
10.1.9 ILLUMINA INC
10.1.10 LC SCIENCES
10.1.11 LIFEGEN TECHNOLOGIES
10.1.12 LIFE TECHNOLOGIES CORP
10.1.13 MACROGEN INC
10.1.14 MICROARRAYS INC
10.1.15 NGK INSULATORS LTD
10.1.16 ROCHE NIMBLEGEN INC
10.1.17 SIGMA-ALDRICH
10.2 DNA and Gene Chip Sales Date of Major Players (2017-2020e)
10.2.1 AFFYMETRIX INC
10.2.2 AGILENT TECHNOLOGIES INC
10.2.3 BIOMIEUX SA
10.2.4 BIOMETRIX TECHNOLOGY INC
10.2.5 BIONEER CORP
10.2.6 CAPITALBIO CORP
10.2.7 EUROFINS MWG OPERON
10.2.8 GREINER BIO-ONE
10.2.9 ILLUMINA INC
10.2.10 LC SCIENCES
10.2.11 LIFEGEN TECHNOLOGIES
10.2.12 LIFE TECHNOLOGIES CORP
10.2.13 MACROGEN INC
10.2.14 MICROARRAYS INC
10.2.15 NGK INSULATORS LTD
10.2.16 ROCHE NIMBLEGEN INC
10.2.17 SIGMA-ALDRICH
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table DNA and Gene Chip Product Type Overview
2.Table DNA and Gene Chip Product Type Market Share List
3.Table DNA and Gene Chip Product Type of Major Players
4.Table Brief Introduction of AFFYMETRIX INC
5.Table Brief Introduction of AGILENT TECHNOLOGIES INC
6.Table Brief Introduction of BIOMIEUX SA
7.Table Brief Introduction of BIOMETRIX TECHNOLOGY INC
8.Table Brief Introduction of BIONEER CORP
9.Table Brief Introduction of CAPITALBIO CORP
10.Table Brief Introduction of EUROFINS MWG OPERON
11.Table Brief Introduction of GREINER BIO-ONE
12.Table Brief Introduction of ILLUMINA INC
13.Table Brief Introduction of LC SCIENCES
14.Table Brief Introduction of LIFEGEN TECHNOLOGIES
15.Table Brief Introduction of LIFE TECHNOLOGIES CORP
16.Table Brief Introduction of MACROGEN INC
17.Table Brief Introduction of MICROARRAYS INC
18.Table Brief Introduction of NGK INSULATORS LTD
19.Table Brief Introduction of ROCHE NIMBLEGEN INC
20.Table Brief Introduction of SIGMA-ALDRICH
21.Table Products & Services of AFFYMETRIX INC
22.Table Products & Services of AGILENT TECHNOLOGIES INC
23.Table Products & Services of BIOMIEUX SA
24.Table Products & Services of BIOMETRIX TECHNOLOGY INC
25.Table Products & Services of BIONEER CORP
26.Table Products & Services of CAPITALBIO CORP
27.Table Products & Services of EUROFINS MWG OPERON
28.Table Products & Services of GREINER BIO-ONE
29.Table Products & Services of ILLUMINA INC
30.Table Products & Services of LC SCIENCES
31.Table Products & Services of LIFEGEN TECHNOLOGIES
32.Table Products & Services of LIFE TECHNOLOGIES CORP
33.Table Products & Services of MACROGEN INC
34.Table Products & Services of MICROARRAYS INC
35.Table Products & Services of NGK INSULATORS LTD
36.Table Products & Services of ROCHE NIMBLEGEN INC
37.Table Products & Services of SIGMA-ALDRICH
38.Table Market Distribution of Major Players
39.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
40.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
41.Table Global DNA and Gene Chip Market Forecast (Million USD) by Region 2021f-2026f
42.Table Global DNA and Gene Chip Market Forecast (Million USD) Share by Region 2021f-2026f
43.Table Global DNA and Gene Chip Market Forecast (Million USD) by Demand 2021f-2026f
44.Table Global DNA and Gene Chip Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
